Folate deficiency causes megaloblastic anemia and neural tube defects, and is also associated with some cancers. In vitro, folate deficiency increases mutation frequency and genome instability, as well as exacerbates the mutagenic potential of known environmental mutagens. Conversely, it remains unclear whether or not elevated folic acid (FA) intakes are beneficial or detrimental to the induction of DNA mutations and by proxy human health. We used the MutaMouse transgenic model to examine the in vivo effects of FA deficient, control, and supplemented diets on somatic DNA mutant frequency (MF) and genome instability in hematopoietic cells. We also examined the interaction between FA intake and exposure to the known mutagen Nethyl-N-nitrosourea (ENU) on MF. Male mice were fed the experimental diets for 20 weeks from weaning. Half of the mice from each diet group were gavaged with 50 mg/kg body weight ENU after 10 weeks on diet and remained on their respective diet for an additional 10 weeks. Mice fed a FA-deficient diet had a 1.3-fold increase in normochromatic erythrocyte micronucleus (MN) frequency (P 5 0.034), and a doubling of bone marrow lacZ MF (P 5 0.035), compared to control-fed mice. Mice exposed to ENU showed significantly higher bone marrow lacZ and Pig-a MF, but there was no effect of FA intake on ENU-induced MF. These data indicate that FA deficiency increases mutations and MN formation in highly proliferative somatic cells, but that FA intake does not mitigate ENU-induced mutations. Also, FA intake above adequacy had no beneficial or detrimental effect on mutations or MN formation. Environ. 
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INTRODUCTION
Folate is an essential water-soluble B-vitamin required for de novo thymidylate (dTMP), purine, and methionine synthesis. Its role in de novo dTMP and purine synthesis makes it important for DNA synthesis and consequently cell proliferation and genome stability. Folate is essential for the production of S-adenosylmethionine (AdoMet), the major cellular methyl donor required for DNA and histone methylation and therefore important for gene expression and genome stability. Folate deficiency has been associated with various diseases including non-alcoholic fatty liver disease, megaloblastic anemia, and colon cancer [Stover, 2009] . Induced mutations and genomic instability are proposed mechanisms underlying the association between folate deficiency and folate-related diseases.
Folate deficiency resulting from either a low folate intake or impairments in folate metabolism decreases de novo nucleotide and AdoMet production, which can lead to genome instability. A decreased availability of purine nucleotides leads to nucleotide pool imbalances, increased mutation rates, decreased cell growth rates, alterations in DNA synthesis and improper DNA repair of UV-induced lesions [Collins et al., 1988; Kondo et al., 2000] . Regarding dTMP synthesis, thymidylate synthase (TYMS) transfers a methylene group from 5,10-methylenetetrahydrofolate (THF) to deoxyuridine monophosphate (dUMP) to form dTMP. Folate deficiency reduces the activity of TYMS which leads to a build-up of dUMP, a precursor of deoxyuridine triphosphate (dUTP). An increase in the intra-cellular pools of dUTP can lead to increased uracil misincorporation into DNA, the repair of which requires the formation of a nick in the DNA. If two DNA nicks are formed in close proximity, DNA double strand breaks (DSBs) can occur [Blount and Ames, 1995; Stover, 2004] . Lower AdoMet production resulting from folate deficiency reduces available methyl groups, which can alter DNA methylation patterns leading to altered gene expression and chromosomal aberrations, including breaks, deletions, duplications and translocations [Ji et al., 1997] . Thus, folate deficiency has the potential to be mutagenic as a result of decreased purine synthesis and clastogenic as a result of decreased dTMP and AdoMet synthesis. For these reasons, it is important to examine the effect of folic acid (FA) intake on mutations and chromosomal damage and instability.
A substantial proportion of the Canadian population potentially consume FA at or above the Upper Tolerable Intake level (1 mg FA/day) [MacFarlane et al., 2011] ; this higher intake of FA may have unknown health effects. FA supplementation in vitro reduces oxidative stress and apoptosis induced by 7-ketocholesterol, a commonly oxidized cholesterol that can induce apoptosis in endothelial cells [Huang et al., 2004] . FA supplementation both in vitro and in vivo also protects against induced mutations and chromosomal damage in human liver cells caused by benzo(a)-pyrene, a strong mutagen and carcinogen [Zhang et al., 2016] . Similarly, FA supplementation reduced chromosomal aberrations in somatic and germ cells, as well as reduced DNA fragmentation in mouse spleen cells treated with daunorubicin, an anticancer drug used in the treatment of multiple malignancies [Aly et al., 2009] . Therefore, it is possible that FA intake above adequate levels could maximize DNA synthesis and repair in conditions of exposure to environmental toxicants, potentially resulting in fewer mutations and clastogenic effects.
Conversely, concerns have also been raised about higher than required intakes of FA. High levels of intracellular FA have been proposed to lead to an accumulation of dihydrofolate, the product of the first step in FA bioactivation. Accumulation of dihydrofolate has been shown to inhibit TYMS and methylene-THF reductase (MTHFR) in vitro, thus inhibiting the formation of dTMP and 5-methyl-THF, respectively, and therefore inhibiting normal DNA and methionine synthesis [Smith et al., 2008] . As such, FA supplementation could potentially mirror the clastogenic effects of folate deficiency by inducing DNA DSBs and chromosomal instability. These concerns remain hypothetical and require further investigation.
Recently our lab demonstrated that BALB/c male mice fed a FA deficient diet had a significantly higher Pig-a mutant frequency (MF) and micronucleus (MN) frequency in reticulocytes (RETs) and red blood cells (RBCs) compared to mice fed a control diet [MacFarlane et al., 2015] . We have also shown that folate deficiency induces an increased Expanded Short Tandem Repeat (ESTR) mutation frequency in the sperm of BALB/c mice [Swayne et al., 2012] .
Here, we used the MutaMouse model to measure mutations in a non-expressed gene target, the lacZ transgene, in bone marrow cells. The MutaMouse has 29 6 4 copies of the lambda bacteriophage vector (kgt10lacZ) containing the lacZ gene in all of its cells [Schwed et al., 2010] . The reporter gene allows for detection of loss of function mutations in E. coli that can be quantified and used to calculate a MF [Lambert et al. 2005] . We also measured mutations in the endogenous Pig-a gene and MN frequency in RETs and RBCs.
MATERIALS AND METHODS

Mice
All mice were cared for in accordance with the Guidelines of the Canadian Council on Animal Care (CACC), described in the CACC Guide to the Care and Use of Experimental Animals [Olfert et al., 1993] . The study was approved by the Health Canada Ottawa Animal Care Committee. Sixty weanling male mice derived from the in-house MutaMouse colony were housed at standard humidity and temperature with a 12 h light cycle. They had ad libitum access to food and water for the duration of the study. At five weeks of age, mice were randomly Environmental and Molecular Mutagenesis. DOI 10.1002/em assigned to one of three FA-defined diets based on the AIN-93G formula [Reeves et al., 1993] and kept on diet for 20 weeks. The diets contained 0 mg/kg FA (deficient), 2 mg/kg FA (control), or 8 mg/kg FA (supplemented) (Dyets, Inc., Bethlehem, PA). The deficient diet (0 mg/kg) is used to represent an inadequate dietary FA intake. We have previously shown that circulating homocysteine doubles in mice fed the same deficient diet for 12 weeks, and results in a higher MN frequency in RBCs [MacFarlane et al., 2013 [MacFarlane et al., , 2015 , indicating that this diet reduces circulating and tissue folate to a meaningful level with effects on both hematological and metabolic indicators. The control diet (2 mg/kg) corresponds with the Recommended Dietary Allowance (RDA) for adult humans, 0.4 mg per day. It is representative of an adequate dietary FA intake for rodents as recommended by the American Institute of Nutrition [Reeves et al., 1993] . The supplemented diet (8 mg/kg) is 4-fold the control diet and is used to represent a dietary FA intake of 1.6 mg per day in adult humans. This level of FA intake is achievable with the combined intake of FA from fortified foods and FA-containing supplements available over-the-counter in Canada. Following 10 weeks on FA-defined diets, half of the mice from each diet group were given a 50 mg/kg BW dose of N-ethyl-N-nitrosurea (ENU) dissolved in phosphate-buffered saline by gavage (n 5 10) and the other half in each diet group (n 5 10) were given saline by gavage. The mice were then kept on their respective diet for another 10 weeks.
Tissue Collection
After 20 weeks on diet, the mice were killed under isoflurane anesthesia by cardiac puncture followed by cervical dislocation. Blood was drawn via cardiac puncture into a heparin coated syringe (5:1 ratio of blood to heparin). Approximately 300 mL of this was transferred to K 2 EDTA collection tubes and sent fresh overnight to Litron Laboratories (Rochester, NY). The remaining blood (400 mL) drawn was separated into RBCs and plasma by centrifugation within an hour of collection. Bone marrow from the right and left femur was flushed out with phosphate-buffered saline, flash frozen in liquid nitrogen and stored at 2808C until use.
RBC and Plasma Folate
RBC and plasma folate was measured for a subset of mice (n 5 5) from each of the six experimental groups using the Lactobacillus casei microbiological assay as previously described [Molloy and Scott, 1997] . RBC folate concentrations were normalized to total protein content quantified using the modified Lowry assay as previously described [Bensadoun and Weinstein, 1976] .
Micronucleus Assay
MN frequency was measured by flow cytometry at Litron Laboratories using a propidium iodide DNA stain, to identify the presence of micronuclei. An antibody against the CD71 surface expressed protein was used to differentiate RETs and normochromatic erythrocytes (NCEs). Cells were sorted according to RETs, NCEs, MN-RETs, and MN-NCEs by flow cytometry, as previously described [Dertinger et al., 2004] . The mean number of NCEs analyzed was 1.05 3 10 6 cells/sample with a minimum of 6.6 3 10 4 cells/sample and the mean number of RETs analyzed was 2.0 3 10 4 with a minimum of 1.98 3 10 4 cells/sample.
Pig-a Assay
Pig-a mutation frequency was measured by flow cytometry at Litron Laboratories using an antibody against the CD24 GPI-anchored protein as previously described [Kimoto et al., 2011] 
Bone Marrow lacZ Mutant Frequency
DNA was extracted from bone marrow using a phenol chloroform method and used in the lacZ assay as described by Gingerich et al. [2014] . A minimum of 125,000 total plaque forming units were screened per animal, following the OECD test guidelines recommendation [OECD, 2013] .
Statistical Analyses
Differences among diet groups for body weight, plasma and RBC folate concentration, Pig-a MF and MN frequency were analyzed for significance by two-way ANOVA and Holm-Sidak post-hoc analysis to determine a diet by ENU treatment effect. If no effect of ENU was observed, a one-way ANOVA and Holm-Sidak post-hoc analysis was performed. In cases where the data failed equal variance or normality, data were log transformed for analysis and a Tukeys post-hoc analysis was performed. Correlations were identified using the Pearson ProductMoment correlation test. Correlation analyses between bone marrow lacZ and Pig-a MF and RBC and plasma folate concentration were performed only for saline exposed mice, whereas correlation analyses between folate concentration and MN frequency were performed on saline and ENU exposed mice combined as there were no significant differences in MN frequency between saline and ENU exposed mice. Because plasma and RBC folate measurements were performed on a subset of animals from each experimental group, the correlation analyses were restricted to this subset (n 5 4-5/diet). A P value 0.05 was considered significant. Analyses were performed using SigmaPlot for Windows, version 13 (Systat Software, Inc.).
Analysis of bone marrow lacZ MF was performed using R (version 3.2.0, www.r-project.org). Bone marrow lacZ MF data were fit to a generalized linear model with a binomial error distribution using the glm function. Overdispersion was permitted among biological replicates using the quasibinomial distribution for glm, as inter-individual variability is known to be high for the lacZ assay. Mice with <125,000 total plaque forming units screened were removed from the analysis. Including the two mice that did not meet the minimum number of PFUs did not alter the statistical outcomes. Replicates that were outside of the expected binomial error distribution were considered outliers and also removed. Based on these criteria a total of five mice were removed out of the 60 mice considered (two that did not meet 125,000 screened plaques and three that were outside the expected error distribution), resulting in a final sample size of 55 mice with 7-10 mice in each of the six experimental groups. Removal of the outliers resulted in a more conservative interpretation of the results. A two-factor analysis setting diet and ENU treatment as factors was performed to identify differences in group means. P values were corrected for multiple-comparisons using the Bonferroni-Holm method. P value cut off was 0.05.
RESULTS
Body Weight
Body weights measured throughout the study period and total weight gain over study duration did not differ significantly among the diet groups (Fig. 1 ).
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Plasma and RBC Folate
Male mice fed a FA deficient and supplemented diet had 6.6-fold lower and 2-fold higher plasma folate concentrations, respectively, compared to male mice fed the control diet (P < 0.05) (Fig. 2A) . Male mice fed a FA deficient and supplemented diet had 8.7-fold lower and 1.3-fold higher RBC folate concentrations, respectively, compared to male mice fed the control diet (P < 0.05) (Fig. 2B) .
Micronucleus Frequency
ENU treatment had no effect on MN frequency due to the 10-week period between ENU treatment and sample collection which allowed for the removal of MN-NCEs from circulation. As such, data from both saline and ENU-treated groups were combined for MN analysis among the FA diets. The % RETs did not differ among the diet groups (Fig. 3A) . The frequency of MN-RETs was significantly higher by 1.3-and 1.4-fold in male mice fed a FA deficient diet compared to those fed a FA control (P 5 0.04) and supplemented diet (P 5 0.034), respectively (Fig. 3B) . The frequency of MN-NCEs was significantly higher by 1.3-fold in male mice fed a FA deficient diet compared to those fed a FA control diet (P 5 0.034). MN-NCE frequency in FA deficient mice also tended to be higher compared to those fed a FA supplemented diet, but this effect was not significant (P 5 0.071) (Fig. 3C) . The % RETs, MN-RETs, and MNNCEs frequencies did not differ between mice fed the control and supplemented diets. MN-RETs were negatively correlated with plasma (Correlation coefficient, r 5 20.519, P 5 0.003) and RBC (Correlation coefficient, r 5 20.492, P 5 0.006) folate concentration. MN-NCEs were negatively correlated with RBC folate concentration (Correlation coefficient, r 5 20.405, P 5 0.026). MN- Fig. 2 . Plasma folate (A) and RBC folate (B). *, significantly different than control, one-way ANOVA, Tukeys post-hoc analysis (P < 0.05). Data are presented as mean 6 SEM. Fig. 3 . The % RETs, and MN-RET and MN-NCE frequencies in male mice fed FA-defined diets. No ENU-treatment effect was observed; therefore ENU and saline data were combined for analysis. A main diet effect on MN-RET frequency and MN-NCE frequency was observed (P < 0.05) using a two-way ANOVA, Holm-Sidak post-hoc analysis. (A) % RETs, (B) MN-RET frequency, (C) MN-NCE frequency. The black line represents the mean of the group. *, significantly different based on a two-way ANOVA, Holm-Sidak post-hoc analysis. A minimum of 1.98 3 10 4 and 6.6 3 10 5 cells/sample were measured for RETs and NCEs, respectively.
NCEs tended to negatively correlate with plasma folate, but it was not significant (Correlation coefficient, r 5 20.347, P 5 0.06) (Fig. 4) .
Bone Marrow lacZ Mutant Frequency
Among saline-treated mice, mice fed the FA deficient diet had a significant 1.9-fold higher bone marrow lacZ MF compared to those fed the control FA diet (P 5 0.035, Fig. 5A ). All groups treated with ENU had significantly higher bone marrow lacZ MF compared to mice treated with saline (Fig. 5A,B) . The FA diet did not have an effect on the ENU-induced increase in lacZ MF (Fig. 5B) . In saline-treated mice, bone marrow lacZ MF was negatively correlated with plasma folate concentration (Correlation coefficient, r 5 20.688, P 5 0.009) and RBC folate concentration (Correlation coefficient, r 5 20.631, P 5 0.012) (Fig. 6 ). Including mice with <125,000 plaques in the statistical analysis did not alter the results.
Pig-a Mutant Frequency
ENU-treated mice had higher Pig-a RET and RBC MF than saline-treated mice (P < 0.001). Diet had no effect on % RETs, RET MF and RBC MF, in either saline or ENU-treated mice and did not interact with ENU treatment (Fig. 7) . In saline exposed mice, Pig-a MF did not correlate with RBC or plasma folate concentration.
DISCUSSION
Folate deficiency has been associated with cardiovascular disease, gastrointestinal cancers, and is known to cause neural tube defects (NTDs); however, the specific underlying mechanisms remain unclear. In this study, we demonstrate that highly proliferative bone marrow cells are susceptible to the induction of mutations and chromosomal damage in conditions of folate deficiency. FA supplementation provided no additional mitigation of these endpoints compared to mice fed the adequate diet. Our data also indicate that the frequency of ENU-induced mutations is not modulated by FA diet, or at least at the dose of ENU used in the present study. Overall, FA supplementation provided no additional protection from mutations and chromosomal instability when compared to adequate FA intake. Folate deficiency has the potential to induce DNA DSBs through two pathways: de novo dTMP synthesis and methionine synthesis. We show that FA deficiency induced a 1.3-and 1.4-fold increase in the frequency of MN-RETs compared to a FA control and supplemented diet, respectively. Similarly, FA deficiency induced a 1.3-fold increase in MNNCEs compared to the FA control diet. These results are comparable to our previous findings in BALB/c mice where FA deficiency induced a 1.8-and 2-fold and 1.5-and 1.6-fold higher MN-RETs and MN-NCEs frequencies, respectively, compared to mice fed FA control or supplemented diets [MacFarlane et al., 2015] . These results indicate that folate deficiency consistently induces chromosomal damage, likely due to the induction of DNA DSBs in precursors of RETs and RBCs. FA supplementation had no effect on MN formation in RETs or NCEs compared to adequacy. MN frequency was negatively correlated with RBC folate concentration, indicating that MN frequency is associated with folate status.
Our studies inform previous observations made in human subjects. In splenectomized humans, who have reduced capacity for clearance of MN-NCEs and MNRETs from circulation, it has been shown that plasma folate is negatively correlated with micronucleated erythrocytes . Furthermore, splenectomized individuals that are folate deficient (4 ng/mL) or even marginally deficient (4.9-6.8 ng/mL) have a higher frequency of MN-RETs and MN-RBCs compared to folate adequate individuals [Blount et al., 1997; Everson et al., 1988] . These data indicate that the relationship between folate status and micronucleus formation in humans is continuous even above the cut off for folate deficiency.
Folate deficiency is known to cause megaloblastic anemia making bone marrow an ideal tissue to study the impact of folate on mutations as it is a highly proliferative tissue with a high demand for folate. We observed an approximately 2-fold higher lacZ MF in mice fed a FA deficient diet compared to mice fed the control diet. Mice fed the FA-deficient diet had a mean lacZ MF of 9.7 6 1.4 3 10 25 compared to a lacZ MF of 5.2 6 0.97 3 10 25 in mice fed the control diet. The spontaneous lacZ MF for bone marrow observed in mice fed the control diet was comparable to the historical control spontaneous lacZ MF of 5.3 6 1.7 3 10 25 in the Health Canada MutaMouse colony (Marchetti, unpublished data). Mice fed the FA supplemented diet did not have a different MF than the control fed mice. In addition to DNA DSBs, folate deficiency can also induce point mutations by reducing de novo purine synthesis. The lacZ assay is able to detect point mutations and small insertions and deletions up to 3 bp long but not large deletions, such as those induced by DNA DSBs [Lambert et al., 2005; Beal et al., 2015] , therefore we propose that the likely mechanism contributing to the increased lacZ MF in mice exposed to a FA deficient diet is impaired de novo purine synthesis. Sequencing the induced lacZ mutations would help confirm the mutational mechanism of FA deficiency.
We noted a few differences in this study compared to a similar study in male BALB/c mice fed the same FA deficient diet for 18 weeks from weaning [MacFarlane et al., 2015] . In BALB/c mice fed the FA deficient diet, we saw a slightly higher fold increase in MN-RET and MN-NCEs than observed here, and a significantly higher Pig-a MF in RBCs compared to mice fed a FA supplemented diet (6 mg/kg). We also observed differences among the diet groups in % RETs, although the % RET values were all within the expected range of 1%-6% for adult male mice [Bhardwaj and Saxena, 2013] . The data suggest that the MutaMouse transgenic strain, produced from the fertilization of a BALB/c 3 DBA/2 F1 egg by a BALB/c 3 Fig. 7 . The % RETs and Pig-a MF in male mice fed FA-defined diets and exposed to ENU or saline. A main effect of ENU treatment was observed (P < 0.001) using a two-way ANOVA, Holm-Sidak post-hoc analysis such that ENU induced higher mutation frequency compared to saline treatment. Therefore, graphs were separated by treatment: saline (A, B, C) and ENU (D, E, F). Environmental and Molecular Mutagenesis. DOI 10.1002/em DBA/2 F1 sperm [Lambert et al., 2005] and inbred for multiple generations, is more resistant to the effects of folate deficiency than the BALB/c strain. The difference in susceptibility of the two strains provides a means to place our findings in the context of the human population. Genetic diversity is high within the human population; thus individuals within the population, analogous to the different inbred strains, will have varied susceptibility to environmental/dietary influences. In the case of folate, for example, a gene-nutrient interaction between folate status and the MTHFR 677C > T polymorphism has been shown to modify the risk for colorectal cancer [Ma et al., 1997] .
We expected that a dietary FA intervention would induce comparable results in the Pig-a and bone marrow lacZ assays, as mutations in the bone marrow, which contain RBC precursors, RETs and RBCs, would likely correlate with mutations in circulating RETs and RBCs. However, we observed an effect of FA intake in the lacZ assay but not in the Pig-a assay. The two assays were compared in mice treated with benzo(a)pyrene and it was found that the lacZ assay had a higher mutagenic efficiency with the magnitude of the lacZ response in bone marrow 25-fold higher than that of the Pig-a assay [Lemieux et al., 2011] . Here, Pig-a MF and bone marrow lacZ MF were not correlated in saline exposed mice; however, the detection of mutants in the lacZ assay appears to be an order of magnitude higher than mutants in the Pig-a assay ( Supporting Information, Figure 1) . Although Pig-a is an endogenous gene and lacZ is not, mutations in both are considered to be functionally neutral in RETs and RBCs [Lambert et al., 2005; Miura, 2014] . Thus, there is theoretically no selective disadvantage for Pig-a mutants over lacZ mutants. We therefore suggest that the lacZ transgene is more sensitive to mutation induction because it is not transcribed in the mouse whereas the Pig-a gene undergoes transcription and is therefore subject to transcription-coupled repair [Lemieux et al., 2011] . We propose that the transcription coupled repair of the Pig-a gene results in a lower MF, even in a state of FA deficiency. In addition, there are 29 6 4 copies of the lacZ gene per cell, whereas only one copy of the Pig-a gene exists per cell making it a more likely target [Schwed et al., 2010] . Together, it is the characteristics of the two assays that differentiate their sensitivity to detect mutations.
Supplemental FA intake was investigated in this study to address concerns related to the potentially high intake of FA in the Canadian population. However, FA supplementation had no effect, positive or negative, on RBC MN frequency, bone marrow lacZ MF, or Pig-a MF. Previously, in a similar study, our lab observed that FA supplementation did not have an effect of Pig-a or MN frequency [MacFarlane et al., 2015] . Our data indicate that FA supplementation at levels represented in this study provides no additional benefit compared to adequacy, but also has no negative impact on mutagenesis or chromosomal instability.
We were also interested in whether FA intake interacted with an environmental mutagen on mutation induction. Male mice exposed to ENU had >10-fold higher lacZ and Pig-a mutant frequencies compared to those exposed to saline, as would be expected for a known potent chemical mutagen. However, we saw no effect of FA intake on ENU-induced MF using either assay. It is possible that a dose of 50 mg/kg BW ENU induces mutations at too high a frequency for FA intake to mitigate or exacerbate its mutagenic potential. Future studies should investigate whether FA intake can modulate chemicallyinduced mutagenesis at lower mutagen doses, or for mutagens with different modes of action.
CONCLUSIONS
In this study, we determined that folate deficiency increases MN frequency in RBCs and increases lacZ mutations in bone marrow cells in MutaMouse mice. Neither folate deficiency nor FA supplementation had an effect on mutations in the Pig-a gene of RBCs. Contrary to hypothetical concerns, FA supplementation did not have a negative effect on micronuclei formation or somatic mutations; neither did FA supplementation protect or exacerbate the induction of somatic mutations by ENU. These studies emphasize the importance of maintaining a folate adequate diet to minimize genomic instability in somatic cells, as well as identify possible mechanisms underlying the association between folate deficiency and disease in somatic tissues. With the advent of the Pig-a assay and others, it will be possible in the future to investigate and confirm in humans the effect of lower folate status on DNA mutations in circulating somatic cells.
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